Tumour-Effector Cell Avidity is a Key Driver for Cellular Therapy Efficacy
Time: 11:30 am
day: Day 1 - Track A - Morning
Details:
- Avidity is a new key parameter for predicting T-cell function
- Avidity data strongly correlates to in vitro functional assays and preclinical mouse studies
- The z-Movi Cell Avidity Analyzer measures the avidity of lymphocytes with tumour cells at the single-cell level using an extremely quick and easy workflow
